Gilead Sciences Inc (GILD)

May 8, 2025, 7:23 PM EDT - 3 days ago

Pressure is still on the pharma sector, says Mizuho's Jared Holz

ABBV AMGN BMY JNJ LLY MRK NVO

May 7, 2025, 2:52 PM EDT - 4 days ago

Gilead announces $11 billion in new investments in US

May 7, 2025, 2:30 AM EDT - 4 days ago

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment

May 7, 2025, 2:15 AM EDT - 4 days ago

Gilead's Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025

Apr 29, 2025, 4:05 PM EDT - 12 days ago

Gilead Sciences to Present at Upcoming Investor Conferences

Apr 29, 2025, 1:51 PM EDT - 12 days ago

Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors

Apr 29, 2025, 1:45 PM EDT - 12 days ago

Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions

Apr 29, 2025, 8:30 AM EDT - 12 days ago

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

Apr 27, 2025, 7:00 AM EDT - 14 days ago

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks

Apr 25, 2025, 6:06 PM EDT - 16 days ago

We're in a pharma stock pickers market, says Kessef's Len Yaffe

ABBV BMY JNJ LLY MRK PFE REGN

Apr 25, 2025, 10:35 AM EDT - 16 days ago

Gilead Sciences Q1 Earnings Review: HIV Division Masks Underperformance

Apr 25, 2025, 10:30 AM EDT - 16 days ago

AAPL Doubling India iPhone Production, TMUS Sells, GILD Healthcare Headwinds

AAPL TMUS

Apr 25, 2025, 8:27 AM EDT - 16 days ago

Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session

INTC SKX

Apr 24, 2025, 8:02 PM EDT - 17 days ago

Gilead Sciences, Inc. (GILD) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 4:09 PM EDT - 17 days ago

Gilead reports quarterly profit, revenue flat as cancer sales slow

Apr 24, 2025, 4:02 PM EDT - 17 days ago

Gilead Sciences Announces First Quarter 2025 Financial Results

Apr 24, 2025, 1:10 PM EDT - 17 days ago

Stocks on the Move: Merck, Gilead Sciences, P&G, PG&E Corp, Adobe and the URNM

ADBE MRK PCG PG URNM

Apr 21, 2025, 8:38 AM EDT - 20 days ago

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type

Apr 21, 2025, 8:30 AM EDT - 20 days ago

Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer

Apr 10, 2025, 4:05 PM EDT - 4 weeks ago

Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025

Apr 9, 2025, 6:32 PM EDT - 4 weeks ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Apr 4, 2025, 2:01 AM EDT - 5 weeks ago

Top 3 Nasdaq 100 stocks rising as it moves into a correction

EXC TMUS

Apr 2, 2025, 1:52 PM EDT - 5 weeks ago

Final Trades: Gilead Sciences, Amazon, Alphabet and KLA Corp.

AMZN GOOG GOOGL KLAC

Apr 1, 2025, 2:01 PM EDT - 5 weeks ago

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

ABBV AMGN BMY LLY MRK MRNA PFE

Mar 30, 2025, 8:00 AM EDT - 6 weeks ago

Earn A Potentially 12%-15% Income: Monthly Options Series (April 2025)

AMAT APH BK BMY CTAS EOG EQH

Mar 27, 2025, 10:22 AM EDT - 6 weeks ago

Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector.

ABBV AMGN BIIB BMY IHE JNJ LLY

Mar 23, 2025, 12:36 PM EDT - 7 weeks ago

Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval

Mar 19, 2025, 9:22 AM EDT - 7 weeks ago

Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding

Mar 14, 2025, 1:51 PM EDT - 2 months ago

Calls of the Day: Shake Shack, Starbucks, 3M, Gilead Sciences, Eli Lilly

LLY SBUX SHAK MMM

Mar 12, 2025, 8:30 AM EDT - 2 months ago

Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option

Mar 11, 2025, 2:14 PM EDT - 2 months ago

Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript)

Mar 11, 2025, 1:40 PM EDT - 2 months ago

Stocks beating the stock market's recent Trump slump have this in common

ABBV AMGN BAX CVS PM SMCI TPL

Mar 11, 2025, 1:37 PM EDT - 2 months ago

First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

Mar 5, 2025, 1:31 PM EST - 2 months ago

5 Big Biopharmaceutical Stocks That Are Finding Favor

ABBV AMGN JNJ LLY

Mar 4, 2025, 2:04 PM EST - 2 months ago

Gilead Sciences, Inc. (GILD) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 4, 2025, 7:03 AM EST - 2 months ago

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

CORT PRVA TGTX TKO

Mar 3, 2025, 11:21 AM EST - 2 months ago

Gilead Sciences sets aside $200 million to resolve HIV drug probe

Feb 26, 2025, 10:55 PM EST - 2 months ago

Why Gilead Sciences Remains A Buy After A 40% Rally

Feb 25, 2025, 8:00 AM EST - 2 months ago

MEDSIR & Debiopharm Announce the First Patient Dosed in the WIN-B Trial Exploring the Combination of Debio 0123 & Gilead's Trodelvy® in Advanced Breast Cancer

Feb 24, 2025, 8:30 AM EST - 2 months ago

European Medicines Agency Validates Gilead's Marketing Authorization Application and EU-Medicines for All Application for Twice-Yearly Lenacapavir for HIV Prevention

Feb 20, 2025, 4:30 PM EST - 2 months ago

Gilead's Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis

Feb 18, 2025, 12:59 PM EST - 2 months ago

Calls of the Day: Gilead Sciences and Merck

MRK

Feb 18, 2025, 8:30 AM EST - 2 months ago

U.S. FDA Accepts Gilead's New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review

Feb 14, 2025, 1:31 PM EST - 3 months ago

Josh Brown's best stocks

CTVA UNP

Feb 12, 2025, 3:22 PM EST - 3 months ago

Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention

Feb 12, 2025, 8:25 AM EST - 3 months ago

Gilead Sciences: Strong Q4 Results And Huge Progress In HIV

Feb 11, 2025, 8:40 PM EST - 3 months ago

Gilead Sciences, Inc. (GILD) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 4:08 PM EST - 3 months ago

Gilead quarterly results beat estimates

Feb 11, 2025, 4:05 PM EST - 3 months ago

Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend

Feb 11, 2025, 4:02 PM EST - 3 months ago

Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results